Publication: 38

Phase II trial of weekly nab (nanoparticle albumin-bound)-paclitaxel (nab-paclitaxel) (Abraxane®) in combination with gemcitabine in patients with metastatic breast cancer (N0531)
      QxMD      Google Scholar   
Citation:
Ann Oncol vol 20 (3) 449-453
Year:
2009
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
548  
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
CA- 35113, CA-37404, CA-35431, CA-35090, CA-35195, CA-35103, CA-25224, CA-60276, CA-63848, CA-35415, CA-37417, CA-35272, CA-35101, CA- 35269, CA-15083, CA-63849  
Corr. Author:
 
Authors:
           
Networks:
 
Study
NCCTG-0531
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
breast cancer, chemotherapy, gemcitabine, nab-paclitaxel